FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023195146> ?p ?o ?g. }

• W2023195146 endingPage "87" @default.
• W2023195146 startingPage "78" @default.
• W2023195146 abstract "Hypertensive disorders are life-threatening diseases with high morbidity and mortality, affecting billions of individuals worldwide. A multitude of underlying conditions may contribute to hypertension, thus the need for a plethora of treatment options to identify the approach that best meets the needs of individual patients. A growing body of evidence indicates that (1) autoantibodies that bind to and activate the major angiotensin II type I (AT₁) receptor exist in the circulation of patients with hypertensive disorders, (2) these autoantibodies contribute to disease pathophysiology, (3) antibody titers correlate to the severity of the disease, and (4) efforts to block or remove these pathogenic autoantibodies have therapeutic potential. These autoantibodies, termed AT₁ agonistic autoantibodies have been extensively characterized in preeclampsia, a life-threatening hypertensive condition of pregnancy. As reviewed here, these autoantibodies cause symptoms of preeclampsia when injected into pregnant mice. Somewhat surprisingly, these auto antibodies also appear in 3 animal models of preeclampsia. However, the occurrence of AT₁ agonistic autoantibodies is not restricted to pregnancy. These autoantibodies are prevalent among kidney transplant recipients who develop severe transplant rejection and malignant hypertension during the first week after transplantation. AT₁ agonistic autoantibodies are also highly abundant among a group of patients with essential hypertension that are refractory to standard therapy. More recently these autoantibodies have been seen in patients with the autoimmune disease, systemic sclerosis. These 3 examples extend the clinical impact of AT₁ agonistic autoantibodies beyond pregnancy. Research reviewed here raises the intriguing possibility that preeclampsia and other hypertensive conditions are autoimmune diseases characterized by the presence of pathogenic autoantibodies that activate the major angiotensin receptor, AT₁. These pathogenic autoantibodies could serve as presymptomatic biomarkers and therapeutic targets, thereby providing improved medical management for these conditions." @default.
• W2023195146 created "2016-06-24" @default.
• W2023195146 creator A5008276506 @default.
• W2023195146 creator A5009800945 @default.
• W2023195146 date "2013-06-21" @default.
• W2023195146 modified "2023-10-11" @default.
• W2023195146 title "Angiotensin Receptor Agonistic Autoantibodies and Hypertension" @default.
• W2023195146 cites W1557999275 @default.
• W2023195146 cites W1563194902 @default.
• W2023195146 cites W1867300354 @default.
• W2023195146 cites W1965988736 @default.
• W2023195146 cites W1967306932 @default.
• W2023195146 cites W1972396626 @default.
• W2023195146 cites W1976213628 @default.
• W2023195146 cites W1980694300 @default.
• W2023195146 cites W1982038074 @default.
• W2023195146 cites W1982192731 @default.
• W2023195146 cites W1986266055 @default.
• W2023195146 cites W1987572316 @default.
• W2023195146 cites W1990996575 @default.
• W2023195146 cites W1992563074 @default.
• W2023195146 cites W1998799923 @default.
• W2023195146 cites W2000476116 @default.
• W2023195146 cites W2003050938 @default.
• W2023195146 cites W2003774981 @default.
• W2023195146 cites W2005539077 @default.
• W2023195146 cites W2016453383 @default.
• W2023195146 cites W2018240474 @default.
• W2023195146 cites W2029078217 @default.
• W2023195146 cites W2034460009 @default.
• W2023195146 cites W2036337541 @default.
• W2023195146 cites W2036894466 @default.
• W2023195146 cites W2043306688 @default.
• W2023195146 cites W2047852779 @default.
• W2023195146 cites W2049402890 @default.
• W2023195146 cites W2056670275 @default.
• W2023195146 cites W2057441702 @default.
• W2023195146 cites W2061794578 @default.
• W2023195146 cites W2064143839 @default.
• W2023195146 cites W2064317072 @default.
• W2023195146 cites W2065425901 @default.
• W2023195146 cites W2069284859 @default.
• W2023195146 cites W2074747030 @default.
• W2023195146 cites W2075337276 @default.
• W2023195146 cites W2079052124 @default.
• W2023195146 cites W2089221056 @default.
• W2023195146 cites W2096582474 @default.
• W2023195146 cites W2098547693 @default.
• W2023195146 cites W2100882272 @default.
• W2023195146 cites W2101108251 @default.
• W2023195146 cites W2103034130 @default.
• W2023195146 cites W2103391147 @default.
• W2023195146 cites W2103803344 @default.
• W2023195146 cites W2105632053 @default.
• W2023195146 cites W2106742477 @default.
• W2023195146 cites W2117185007 @default.
• W2023195146 cites W2117431149 @default.
• W2023195146 cites W2118024111 @default.
• W2023195146 cites W2125314742 @default.
• W2023195146 cites W2129459717 @default.
• W2023195146 cites W2132834681 @default.
• W2023195146 cites W2132961242 @default.
• W2023195146 cites W2136003807 @default.
• W2023195146 cites W2136474992 @default.
• W2023195146 cites W2140748581 @default.
• W2023195146 cites W2140785684 @default.
• W2023195146 cites W2143180984 @default.
• W2023195146 cites W2143396987 @default.
• W2023195146 cites W2143764193 @default.
• W2023195146 cites W2145729033 @default.
• W2023195146 cites W2146371213 @default.
• W2023195146 cites W2150087846 @default.
• W2023195146 cites W2152804345 @default.
• W2023195146 cites W2156027990 @default.
• W2023195146 cites W2156276488 @default.
• W2023195146 cites W2157046471 @default.
• W2023195146 cites W2158012243 @default.
• W2023195146 cites W2161694484 @default.
• W2023195146 cites W2162381208 @default.
• W2023195146 cites W2164787449 @default.
• W2023195146 cites W2164878633 @default.
• W2023195146 cites W2166176548 @default.
• W2023195146 cites W2167950650 @default.
• W2023195146 cites W2169154968 @default.
• W2023195146 cites W2313470049 @default.
• W2023195146 cites W1966426672 @default.
• W2023195146 doi "https://doi.org/10.1161/circresaha.113.300752" @default.
• W2023195146 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4131731" @default.
• W2023195146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23788505" @default.
• W2023195146 hasPublicationYear "2013" @default.
• W2023195146 type Work @default.
• W2023195146 sameAs 2023195146 @default.
• W2023195146 citedByCount "133" @default.
• W2023195146 countsByYear W20231951462013 @default.
• W2023195146 countsByYear W20231951462014 @default.
• W2023195146 countsByYear W20231951462015 @default.
• W2023195146 countsByYear W20231951462016 @default.
• W2023195146 countsByYear W20231951462017 @default.

• next